Impact of limited population diversity of genome-wide association studies

Genetics in Medicine

Volumn 12, Issue 2, 2010, Pages 81-84

  Haga, Susanne B ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

Disparities; Genome wide association studies; Race

Indexed keywords

ETHNIC DIFFERENCE; ETHNICITY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENETICS; GENOMICS; HUMAN; METAGENOMICS; MINORITY GROUP; NOTE; RACE DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC TESTING; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; POPULATION GROUPS; UNITED STATES;

EID: 77149140796     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181ca2bbf     Document Type: Note

References (73)

1. National Human Genome Research Institute. Office of Population Genom-ics: a catalog of published genome-wide association studies 2009 http://www.genome.gov/gwastudies. Accessed June 17, 2009.
2. Goldstein DB. Common genetic variation and human traits. N Engl J Med 2009;360:1696-1698.
3. Kraft P, Hunter DJ. Genetic risk prediction-are we there yet? N Engl J Med 2009;360:1701-1703.
4. Hirschhorn JN. Genomewide association studies-illuminating biologic pathways. N Engl J Med 2009;360:1699-1701.
5. Office of Management and Budget (OMB). Federal Register Directive 15.1997.Availableat:http://www.whitehouse.gov/omb/fedreg-directive- 15. Accessed July 15, 2009.
6. Ioannidis JP. Population-wide generalizability of genome-wide discovered associations. J Natl Cancer Inst 2009;101:1297-1299.
7. Yamada H, Penney KL, Takahashi H, et al. Replication of prostate cancer risk loci in a Japanese case-control association study. J Natl Cancer Inst 2009;101:1330-1336.
8. Gudbjartsson DF, Arnar DO, Helgadottir A, et al. Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 2007;448:353-357.
9. Helgason A, Palsson S, Thorleifsson G, et al. Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007;39:218-225.
10. Shin HD, Kim I, Choi CB, Lee SO, Lee HW, Bae SC. Different genetic effects of interferon regulatory factor 5 (IRF5) polymorphisms on systemic lupus erythematosus in a Korean population. J Rheumatol 2008;35:2148-2151.
11. Omori S, Tanaka Y, Takahashi A, et al. Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 2008;57:791-795.
12. Nutbeam D. Health literacy as a public health goal: a challenge for contemporary health education and communication strategies into the 21st century. Health Promotion Int 2000;15:259-267.
13. Horikawa Y, Miyake K, Yasuda K, et al. Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endo-crinol Metab 2008;93:3136-3141.
14. Xiong DH, Liu XG, Guo YF, et al. Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet 2009;84:388-398.
15. Yajnik CS, Janipalli CS, Bhaskar S, et al. FTO gene variants are strongly associated with type 2 diabetes in South Asian Indians. Diabetologia 2009; 52:247-252.
16. Lewis JP, Palmer ND, Hicks PJ, et al. Association analysis in African Americans of European-derived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes 2008;57:2220-2225.
17. NCI-NHGRI Working Group on Replication in Association Studies, Chanock SJ, Manolio T, et al. Replicating genotype-phenotype associations. Nature 2007;447:655-660.
18. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009;461:747-753.
19. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009;461:399-401.
20. National Institutes of Health. NIH Policy and Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Research-Amended, October, 2001. Available at: http://grants.nih.gov/grants/funding/women-min/ guidelines-amended-10-2001.htm. Accessed July 15, 2009.
21. National Institutes of Health Revitalization Act of 1993. Public Law 103-143
22. Department of Health and Human Services. RFA-HG-07-014: Epidemio-logic Investigation of Putative Causal Genetic Variants-Study Investigators (U01). 2008. Available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-07-014. html. Accessed July 2009.
23. Paskett ED, Reeves KW, McLaughlin JM, et al. Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials 2008;29: 847-861.
24. Sateren WB, Trimble EL, Abrams J, et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 2002;20:2109-2117.
25. Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepre-sented populations to cancer clinical trials: a systematic review. Cancer 2008;112:228-242.
26. Corbie-Smith G, Thomas SB, Williams MV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 1999;14:537-546.
27. Advani AS, Atkeson B, Brown CL, et al. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer 2003;97:1499-1506.
28. Katz RV, Green BL, Kressin NR, Claudio C, Wang MQ, Russell SL. Willingness of minorities to participate in biomedical studies: confirmatory findings from a follow-up study using the Tuskegee Legacy Project Questionnaire. J Natl Med Assoc 2007;99:1052-1060.
29. Espeland MA, Dotson K, Jaramillo SA, et al. Consent for genetics studies among clinical trial participants: findings from Action for Health in Diabetes (Look AHEAD). Clin Trials 2006;3:443-456.
30. Catz DS, Green NS, Tobin JN, et al. Attitudes about genetics in underserved, culturally diverse populations. Community Genet 2005;8:161-172.
31. McQuillan GM, Porter KS, Agelli M, Kington R. Consent for genetic research in a general population: the NHANES experience. Genet Med 2003;5:35-42.
32. Wang SS, Fridinger F, Sheedy KM, Khoury MJ. Public attitudes regarding the donation and storage of blood specimens for genetic research. Community Genet 2001;4:18-26.
33. Mezuk B, Eaton WW, Zandi P. Participant characteristics that influence consent for genetic research in a population-based survey: the Baltimore epidemiologic catchment area follow-up. Community Genet 2008;11:171-178.
34. Moorman PG, Skinner CS, Evans JP, et al. Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomarkers Prev 2004;13: 1349-1354.
35. DiMartino L, Allen KD, Kasarskis E, et al. Characteristics associated with participation in DNA banking: the National Registry of Veterans with ALS. Contemp Clin Trials 2007;28:572-582.
36. Royal C, Baffoe-Bonnie A, Kittles R, et al. Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol 2000;10(8 Suppl):S68-S77.
37. Halbert CH, Kessler L, Stopfer JE, Domchek S, Wileyto EP. Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med 2006;8:576-582.
38. Furr LA. Perceptions of genetics research as harmful to society: differences among samples of African-Americans and European-Americans. Genet Test 2002;6:25-30.
39. Bussey-Jones J, Henderson G, Garrett J, Moloney M, Blumenthal C, Corbie-Smith G. Asking the right questions: views on genetic variation research among black and white research participants. J Gen Intern Med 2009;24: 299-304.
40. Thompson HS, Valdimarsdottir HB, Jandorf L, Redd W. Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women. Patient Educ Couns 2003;51:217-227.
41. Wendler D, Kington R, Madans J, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med 2006;3:e19.
42. Nguyen TT, Somkin CP, Ma Y. Participation of Asian-American women in cancer chemoprevention research: physician perspectives. Cancer 2005; 104(12 Suppl):3006-3014.
43. Paskett ED, Katz ML, DeGraffinreid CR, Tatum CM. Participation in cancer trials: recruitment of underserved populations. Clin Adv Hematol Oncol 2003;1:607-613.
44. Brown BA, Long HL, Gould H, Weitz T, Milliken N. A conceptual model for the recruitment of diverse women into research studies. J Womens Health Gend Based Med 2000;9:625-632.
45. Durant RW, Davis RB, St. George DM, Williams IC, Blumenthal C, Corbie-Smith GM. Participation in research studies: factors associated with failing to meet minority recruitment goals. Ann Epidemiol 2007;17:634-642.
46. Brown DR, Topcu M. Willingness to participate in clinical treatment research among older African Americans and Whites. Gerontologist 2003;43: 62-72.
47. Freimuth VS, Quinn SC, Thomas SB, Cole G, Zook E, Duncan T. African Americans' views on research and the Tuskegee Syphilis Study. Soc Sci Med 2001;52:797-808.
48. Shavers-Hornaday VL, Lynch CF, Burmeister LF, Torner JC. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health 1997;2:31-45.
49. National Institutes of Health. NIH Clinical Center: Are Clinical Studies for You?2009. Available at:http://www.cc.nih.gov/participate/studies.shtml. Accessed July 2009.
50. Veterans Health Administration. Volunteering in Research. 2009. Available at: http://www.research.va.gov/programs/pride/veterans/Volunteering-in- Research.pdf. Accessed July 2009
51. AIDS Community Research Initiative of America. ACRIA: Clinical Research: The purpose of clinical trials. 2000. Available at: http://acria.org/ clinical/clinical-res-explained.html. Accessed July 2009.
52. Gadegbeku CA, Stillman PK, Huffman MD, Jackson JS, Kusek JW, Jam-erson KA. Factors associated with enrollment of African Americans into a clinical trial: results from the African American study of kidney disease and hypertension. Contemp Clin Trials 2008;29:837-842.
53. Adderley-Kelly B, Green PM. Strategies for successful conduct of research with low-income African American populations. Nurs Outlook 2005;53: 147-152.
54. Fulton P, Tierney J, Mirpourian N, Ericsson JM, Wright JT Jr, Powel LL. Engaging black older adults and caregivers in urban communities in health research. J Gerontol Nurs 2002;28:19-27.
55. Johnson JA. Ethnic differences in cardiovascular drug response: potential contribution of pharmacogenetics. Circulation 2008;118:1383-1393.
56. International Warfarin Pharmacogenetics Consortium, Klein TE, Altman RB, et al. Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 2009;360:753-764.
57. Wagenknecht LE, Langefeld CD, Scherzinger AL, et al. Insulin sensitivity, insulin secretion, and abdominal fat: the Insulin Resistance Atherosclerosis Study (IRAS) Family Study. Diabetes 2003;52:2490-2496.
58. Bachman DL, Stuckey M, Ebeling M, et al. Establishment of a predominantly African-American cohort for the study of Alzheimer's disease: the South Carolina Alzheimer's disease clinical core. Dement Geriatr Cogn Disord 2009;27:329-336.
59. Kaiser J. Genomic medicine. African-American population biobank proposed. Science 2003;300:1485.
60. MD Anderson Cancer Center. Mexican-American Health Study (Mano a Mano). 2009. Available at: http://www.mdanderson.org/patient-and-cancerinformation/ cancer-information/prevention-research-studies/mexican-americanhealth-study- mano-a-mano-prevention-research-studies.html. Accessed August 4, 2009.
61. Slone Epidemiology Center at Boston University. Black Women's Health Study.2009. Available at:http://www.bu.edu/bwhs. Accessed August 4,2009.
62. National Heart Lung and Blood Institute (NHLBI). Puerto Rico Heart Health Program (PRHHP). 2009. Available at: http://www.nhlbi.nih.gov/resources/ deca/descriptions/prhhp.htm. Accessed August 4, 2009.
63. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA 1999;282:583-589.
64. Martinez E, Tatum KL, Weber DM, et al. Issues related to implementing a smoking cessation clinical trial for cancer patients. Cancer Causes Control 2009;20:97-104.
65. King WD, Defreitas D, Smith K, et al. Attitudes and perceptions of AIDS clinical trials group site coordinators on HIV clinical trial recruitment and retention: a descriptive study. AIDS Patient Care STDS 2007;21:551-563.
66. Ramirez AG, Wildes K, Talavera G, Napoles-Springer A, Gallion K, Perez-Stable EJ. Clinical trials attitudes and practices of Latino physicians. Con-temp Clin Trials 2008;29:482-492.
67. Powell JH, Fleming Y, Walker-McGill CL, Lenoir M. The project IMPACT experience to date: increasing minority participation and awareness of clinical trials. J Natl Med Assoc 2008;100:178-187.
68. McBride CM, Alford SH, Reid RJ, Larson EB, Baxevanis AD, Brody LC. Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med 2009;11:582-587.
69. Goddard KA, Moore C, Ottman D, Szegda KL, Bradley L, Khoury MJ. Awareness and use of direct-to-consumer nutrigenomic tests, United States, 2006. Genet Med 2007;9:510-517.
70. Bates BR, Lynch JA, Bevan JL, Condit CM. Warranted concerns, warranted outlooks: a focus group study of public understandings of genetic research. Soc Sci Med 2005;60:331-344.
71. Bates BR, Poirot K, Harris TM, Condit CM, Achter PJ. Evaluating direct-to-consumer marketing of race-based pharmacogenomics: a focus group study of public understandings of applied genomic medication. J Health Commun 2004;9:541-559.
72. Condit C, Templeton A, Bates BR, Bevan JL, Harris TM. Attitudinal barriers to delivery of race-targeted pharmacogenomics among informed lay persons. Genet Med 2003;5:385-392. (Pubitemid 37264988)
73. Bevan JL, Lynch JA, Dubriwny TN, et al. Informed lay preferences for delivery of racially varied pharmacogenomics. Genet Med 2003;5:393-399.